The Continuous Renal Replacement Therapy (CRRT) Market is Estimated to grow at CAGR of 7-9% by 2027

Factors driving global CRRT market: increasing AKI prevalence, rising geriatric population, growing sepsis occurrence, and clinical advantage of CRRT over intermittent blood purification.
 
BRUSSELS - May 30, 2023 - PRLog -- CRRT (https://meditechinsights.com/continuous-renal-replacement-therapy-market/) is a slow and gentle method of dialysis that removes excess fluids and waste products from the blood in a continuous basis, much like the kidneys function in healthy individuals.

Adoption of CRRT for the Treatment of Critically ill Patients with Acute Kidney Injury (AKI) Drives Demand in Continuous Renal Replacement Therapy (CRRT) Market

Acute Kidney Injury (AKI) is a global problem and is common among critically ill patients. Estimated, 13.3 million people globally are affected by AKI every year, ~85% of which live in developing nations. The goals of CRRT for critically ill patients with AKI include maintaining fluid, electrolyte, acid-base, and solute balance, supporting renal recovery, and allowing other supportive interventions to proceed without complication.

Advantages Associated with CRRT Drives the Continuous Renal Replacement Therapy (CRRT) Market Growth

Critically ill patients with AKI undergoing RRT often experience episodes of hemodynamic instability. CRRT may have a better hemodynamic profile compared with intermittent therapies, including intermittent hemodialysis (IHD) and sustained low-efficiency dialysis. Among the CRRT's advantages, compared to other RRT, is preventing changes in intracerebral water. CRRT is also considered safer than IHD in patients at risk of cerebral edema.

Increasing Awareness Regarding Kidney Health & Prevention Program Drives the Renal Replacement Therapy (CRRT) Market

Presently, a large number of kidney health & prevention programs are run by organizations such as National Kidney Foundation (NKF), The National Kidney Disease Education Program (NKDEP)

§  In September 2022, Fresenius Medical Care, signed a MoU with the National Kidney Foundation (NKF) Malaysia to join efforts in raising awareness about kidney health and the prevention of chronic kidney disease.

North America Expected to Continue to Hold a large Share in the Continuous Renal Replacement Therapy (CRRT) Market

This can be primarily attributed to the growing incidences of AKI, technological advancements in CRRT products, and rising number of diabetic patients,

Key Players in the market: Baxter, B. Braun, Fresenius Medical Care AG, Medtronic, and Nipro Corporation, among others.

Organic and Inorganic Growth Strategies Adopted by Players to Establish Their Foothold in the Market

§  In August 2022, Fresenius Medical Care closed a three-way merger including Fresenius Health Partners, the value-based care division of Fresenius Medical Care North America, and created a premier value-based kidney care provider in the U.S

§  In April 2022, Baxter International Inc. announced the U.S. FDA 510(k) clearance of the company's ST Set used in continuous renal replacement therapy (CRRT)

Get Detailed Insights on the Continuous Renal Replacement Therapy (CRRT) Market @ https://meditechinsights.com/continuous-renal-replacement-therapy-market/

Contact
Ruta Halde
info@meditechinsights.com
+ 32 498 86 80 79
End
Source: » Follow
Email:***@meditechinsights.com
Posted By:***@meditechinsights.com Email Verified
Tags:Continuous Renal Replacement
Industry:Health
Location:Brussels - Brussels - Belgium
Account Email Address Verified     Account Phone Number Verified     Disclaimer     Report Abuse
Medi-tech Insights PRs
Most Viewed
Top Monthly News



Like PRLog?
9K2K1K
Click to Share